InsiderTrades

Form 4 for AMRX Amneal Pharmaceuticals, Inc.

Accepted 2025-05-08 00:00:00 ET · period of report 2025-05-05 · accession 0001628280-25-023989 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-05-08 2025-05-05 AMRX George Jeffrey P. Dir M - OptEx — +40.3K 309.8K +15% —
D 2025-05-08 2025-05-05 AMRX George Jeffrey P. Dir M - OptEx $0.00 -40.3K 0 -100% $0
D 2025-05-08 2025-05-06 AMRX George Jeffrey P. Dir A - Grant $0.00 +34.8K 34.8K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-05-05 M A 40,258 — 309,795 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2 Derivative Restricted Stock Units 2025-05-05 M D 40,258 $0.00 0 D — · — to — 40,258 Class A Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F2) On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.
3 Derivative Restricted Stock Units 2025-05-06 A A 34,819 $0.00 34,819 D — · — to — 34,819 Class A Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F3) Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.